By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tragara Pharmaceuticals, Inc. 

10955 Vista Sorrento Parkway
Suite 120
San Diego  California  92130  U.S.A.
Phone: 858-350-6911 Fax: 858-350-6925



Company News
Tragara Pharmaceuticals, Inc. Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients 6/7/2011 8:14:40 AM
Tragara Pharmaceuticals, Inc.' Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis 5/26/2011 5:00:38 PM
Tragara Pharmaceuticals, Inc. Initiates Phase I Clinical Program for TG02 9/9/2010 10:32:45 AM
Patient Enrollment Complete in Tragara Pharmaceuticals, Inc.'s Phase II Trial of Capoxigem(R) in Non-Small Cell Lung Cancer 4/6/2010 11:20:14 AM
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma 3/29/2010 1:07:43 PM
Tragara Pharmaceuticals, Inc. Raises $5 Million 2/9/2010 7:55:48 AM
S*Bio and Tragara Pharmaceuticals, Inc. Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317; S*BIO Eligible to Receive Up to $112.5 Million 1/21/2009 6:39:47 AM
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing 3/14/2007 10:29:25 AM